Researchers probe why doctors hesitate to clear penicillin allergies in vulnerable cancer patients
NCT ID NCT06967467
Summary
This study aims to understand the challenges of implementing a program to safely remove penicillin allergy labels for hospitalized cancer patients. Researchers will interview patients and doctors and observe hospital workflows to identify what makes the program easy or hard to use. The goal is to learn how to help doctors give the best possible antibiotics to cancer patients who have reported a penicillin allergy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BETA LACTAM ALLERGY IN PATIENTS WITH A HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.